Numbers were updated in the 12- to 17-year-old category as the previous numbers did not include teens 17 years old. Data is now updated for 12- to 17-year-olds for total adverse events, adverse events rated serious, reports of anaphylaxis, reports of myocarditis and pericarditis, and blood clotting disorders.